3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
5
Renal Insufficiency
1
Interventions
Dexamethasone
2
Azacitidine
2
sacubitril and valsartan sodium hydrate drug combination
1
regorafenib
1
pevonedistat
1
melflufen
1
glucarpidase
1
gamma-Glutamyl Hydrolase
1
copanlisib
1
carfilzomib
1
Thalidomide
1
Methotrexate
1
Leucovorin
1
L-melphalanyl-p-L-fluorophenylalanine ethyl ester
1
Cyclophosphamide
1
Bortezomib
1
Bendamustine Hydrochloride
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Renal Insufficiency
×
melflufen
×
Clear all
NCT03639610
2023-03-10
BRIDGE
Oncopeptides AB
Phase 2
Terminated
35 enrolled
33 charts